The Narcotics Management Bureau (NCB) didn't name any Bollywood celeb for questioning within the medication case after Deepika Padukone, Sara Ali Khan, and Shraddha Kapoor final week. A report revealed in Mid-Day now revealed that the explanation behind NCB taking a backseat in its Bollywood associated medication investigation is the strict instruction of trying to find robust proof in opposition to the celebrities earlier than calling them in for questioning. The every day reported that the ‘prime brass’ has requested the company to concentrate on gathering robust proof first after which calling within the celebrities for questioning. The SIT officers have additionally been requested to query increasingly drug peddlers to hint their hyperlinks with Bollywood celebrities and construct a inflexible proof path to take their subsequent massive step. Confirming that the company has received Bollywood celebrities on its radar, an NCB official informed the every day, “Many celebrities are on our radar. We're conducting surveillance on a few of their telephones.” NCB Director Common Rakesh Asthana reportedly got here to Mumbai not too long ago and had a gathering with the staff investigating the alleged medication syndicating in Bollywood. He reportedly requested his staff to rethink their priorities and concentrate on gathering robust proof in opposition to the accused together with holding a monitor of the celebrities’ involvement within the case. In the meantime, the NCB has not discovered something concrete within the Sushant Singh Rajput dying case.